Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ZAFIRLUKAST vs ZANIDATAMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ZAFIRLUKAST vs ZANIDATAMAB: Safety Overview

Metric ZAFIRLUKAST ZANIDATAMAB
Total FAERS Reports 169 142
Deaths Reported 1 12
Death Rate 0.6% 8.5%
Hospitalizations 41 125
Average Patient Age 61.6 yrs 65.2 yrs
% Female Patients 66.7% 40.2%
FDA Approval Date Aug 25, 2022 N/A
Manufacturer Strides Pharma Science Limited Jazz Pharmaceuticals, Inc.
Route ORAL INTRAVENOUS
Marketing Status Prescription N/A